The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.

Hidenori YoshiiTomoya MitaNaoto KatakamiYosuke OkadaTakeshi OsonoiKatsumi AsoAkira KurozumiSatomi WakasugiFumiya SatoRyota IshiiMasahiko GoshoIichiro ShimomuraHirotaka Watada

Published in: The Journal of clinical endocrinology and metabolism (2022)

Higher HbA1c levels do not always protect against hypoglycemic episodes. Our data demonstrate that using CGM metrics to complement HbA1c monitoring is beneficial, especially in older people, users of insulin and/or sulfonylureas, and patients with chronic kidney disease.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
electronic health record
insulin resistance
big data
metabolic syndrome
adipose tissue